Specialty Pharma ApS: Financial statements 2021
CVR: 38476599
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Specialty Pharma ApS (CVR 38476599) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 639,301 and a net result of DKK -44,231 compared with DKK -39,453 the year before. That is a decrease of 32.3% compared with the year before. Equity in the 2021 report amounted to DKK -27,311. The company had 2 employees in the financial year.
- Gross Profit
- DKK 639,301
- Profit/Loss
- DKK -44,231
- Equity
- DKK -27,311
- Total Assets
- DKK 123,587
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 639 t. | -44 t. | -27 t. | 2 |
| 2020 | - | 944 t. | -39 t. | 17 t. | 2 |
| 2019 | - | 819 t. | -14 t. | 56 t. | 2 |
| 2018 | - | 110 t. | -2 t. | 71 t. | 1 |
Official annual report
Find more companies like Specialty Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Specialty Pharma ApS has published its annual report for 2020. Gross profit came to DKK 943,766, and the net result was DKK -39,453.
About Specialty Pharma ApS
Specialty Pharma ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Ulla Haaning Singapuri. The company is owned by Ulla Haaning Singapuri. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 216,735 and a net result of DKK -58,566 compared with DKK -53,758 the year before. Equity in the 2025 report amounted to DKK -17,816.